The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

Ewa Janczewska, Dorota Zarębska-Michaluk, Hanna Berak, Anna Piekarska, Andrzej Gietka, Dorota Dybowska, Włodzimierz Mazur, Teresa Belica-Wdowik, Witold Dobracki, Magdalena Tudrujek-Zdunek, Zbigniew Deroń, Iwona Buczyńska, Marek Sitko, Agnieszka Czauż-Andrzejuk, Beata Lorenc, Jolanta Białkowska-Warzecha, Jolanta Citko, Łukasz Laurans, Jerzy Jaroszewicz, Łukasz Socha, Olga Tronina, Brygida Adamek, Andrzej Horban, Waldemar Halota, Barbara Baka-Ćwierz, Krzysztof Tomasiewicz, Krzysztof Simon, Aleksander Garlicki, Marta Wawrzynowicz-Syczewska, Robert Flisiak

Open source

DOI: 10.1186/s12879-018-3465-2
Published: 2018-11-16
Container: BMC Infectious Diseases
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12879-018-3465-2,
  title = {The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study},
  author = {Ewa Janczewska and Dorota Zarębska-Michaluk and Hanna Berak and Anna Piekarska and Andrzej Gietka and Dorota Dybowska and Włodzimierz Mazur and Teresa Belica-Wdowik and Witold Dobracki and Magdalena Tudrujek-Zdunek and Zbigniew Deroń and Iwona Buczyńska and Marek Sitko and Agnieszka Czauż-Andrzejuk and Beata Lorenc and Jolanta Białkowska-Warzecha and Jolanta Citko and Łukasz Laurans and Jerzy Jaroszewicz and Łukasz Socha and Olga Tronina and Brygida Adamek and Andrzej Horban and Waldemar Halota and Barbara Baka-Ćwierz and Krzysztof Tomasiewicz and Krzysztof Simon and Aleksander Garlicki and Marta Wawrzynowicz-Syczewska and Robert Flisiak},
  year = {2018},
  journal = {BMC Infectious Diseases},
  doi = {10.1186/s12879-018-3465-2},
  url = {https://doi.org/10.1186/s12879-018-3465-2}
}

RIS

TY  - JOUR
TI  - The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study
AU  - Ewa Janczewska
AU  - Dorota Zarębska-Michaluk
AU  - Hanna Berak
AU  - Anna Piekarska
AU  - Andrzej Gietka
AU  - Dorota Dybowska
AU  - Włodzimierz Mazur
AU  - Teresa Belica-Wdowik
AU  - Witold Dobracki
AU  - Magdalena Tudrujek-Zdunek
AU  - Zbigniew Deroń
AU  - Iwona Buczyńska
AU  - Marek Sitko
AU  - Agnieszka Czauż-Andrzejuk
AU  - Beata Lorenc
AU  - Jolanta Białkowska-Warzecha
AU  - Jolanta Citko
AU  - Łukasz Laurans
AU  - Jerzy Jaroszewicz
AU  - Łukasz Socha
AU  - Olga Tronina
AU  - Brygida Adamek
AU  - Andrzej Horban
AU  - Waldemar Halota
AU  - Barbara Baka-Ćwierz
AU  - Krzysztof Tomasiewicz
AU  - Krzysztof Simon
AU  - Aleksander Garlicki
AU  - Marta Wawrzynowicz-Syczewska
AU  - Robert Flisiak
PY  - 2018
JO  - BMC Infectious Diseases
DO  - 10.1186/s12879-018-3465-2
UR  - https://doi.org/10.1186/s12879-018-3465-2
ER  -

APA

Janczewska, E., Zarębska-Michaluk, D., Berak, H., Piekarska, A., Gietka, A., Dybowska, D., Mazur, W., Belica-Wdowik, T., Dobracki, W., Tudrujek-Zdunek, M., Deroń, Z., Buczyńska, I., Sitko, M., Czauż-Andrzejuk, A., Lorenc, B., Białkowska-Warzecha, J., Citko, J., Laurans, Ł., Jaroszewicz, J., Socha, Ł., Tronina, O., Adamek, B., Horban, A., Halota, W., Baka-Ćwierz, B., Tomasiewicz, K., Simon, K., Garlicki, A., Wawrzynowicz-Syczewska, M., & Flisiak, R. (2018). The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study. BMC Infectious Diseases. https://doi.org/10.1186/s12879-018-3465-2

Source records

crossref · retrieved 2026-09-26T18:19:57.395Z